Use of EPA and DHA in secondary prevention
US8729124B2 · kind B2 · utility
1Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2004 |
| Grant date | May 20, 2014 |
| Priority date | — |
| Expiry date | Jun 23, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a method for preventing cerebral damage in patients having symptoms of atherosclerosis of arteries supplying the brain by administering to the patient a therapeutically effective amount of a composition comprising eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or a combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.